{
    "2018-03-19": [
        [
            {
                "time": "2018-03-01",
                "original_text": "GlaxoSmithKlineâ€™s Valuation in March 2018",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "valuation"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Is Novartis (NVS) a Suitable Stock for Value Investors Now?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "value investors"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "VGK, FEU: Big ETF Outflows",
                "features": {
                    "keywords": [
                        "VGK",
                        "FEU",
                        "ETF outflows"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "ETFs"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "The Zacks Analyst Blog Highlights: Biogen, AbbVie, Novartis, Teva and Celgene",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Biogen",
                        "AbbVie",
                        "Novartis",
                        "Teva",
                        "Celgene"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "The Swiss Stock Market Begins The Week With A Loss",
                "features": {
                    "keywords": [
                        "Swiss stock market",
                        "loss"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            }
        ]
    ]
}